ArticleScientific reports2024

Dihydroartemisinin-driven selective anti-lung cancer proliferation by binding to EGFR and inhibition of NRAS signaling pathway-induced DNA damage.

Liu-Gen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.